TrinityBridge Ltd Purchases New Shares in ChronoScale Corporation Common Stock $CHRN

TrinityBridge Ltd purchased a new position in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) during the second quarter, HoldingsChannel reports. The fund purchased 30,729 shares of the company’s stock, valued at approximately $3,880,000.

Several other hedge funds and other institutional investors have also bought and sold shares of CHRN. J.Safra Asset Management Corp acquired a new position in shares of ChronoScale Corporation Common Stock during the 2nd quarter worth approximately $1,085,000. Geode Capital Management LLC increased its holdings in shares of ChronoScale Corporation Common Stock by 68.9% during the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares during the period. Citadel Advisors LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at approximately $198,000. Shay Capital LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at approximately $67,000. Finally, Virtu Financial LLC bought a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at approximately $57,000. Institutional investors and hedge funds own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Trading Up 1.7%

Shares of NASDAQ:CHRN opened at $24.10 on Friday. The company has a market capitalization of $85.80 million, a P/E ratio of -4.48 and a beta of 1.00. ChronoScale Corporation Common Stock has a 1 year low of $3.23 and a 1 year high of $30.00. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.55 and a quick ratio of 1.03. The business’s 50 day simple moving average is $21.82 and its 200 day simple moving average is $15.69.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its quarterly earnings data on Tuesday, June 30th. The company reported ($3.89) EPS for the quarter. The company had revenue of $18.09 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%. On average, research analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.